Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.
Multistep alterations of chromosome 17 in the progression of human urinary bladder neoplasia were studied by superimposed histologic and genetic mapping. The p53 gene was included in the analysis as a model tumor suppressor gene that is frequently involved in urothelial carcinogenesis. The strategy provided a systematic approach to the study of multistep genomic alterations that occur as neoplasia progresses from precursor intraurothelial conditions to invasive cancer. This was accomplished by sampling the entire mucosa of the organ and displaying microscopically identified invasive cancer and precursor conditions in the form of a histologic map. Subsequent isolation of DNA provided a set of samples in which the search for genetic alterations was performed and superimposed on the histologic map. This approach disclosed multifocal allelic losses of chromosome 17 in the early preinvasive phases of urothelial neoplasia. The alterations were predominantly confined to the p12-13, q22-11 and q24-25 regions. Mutations and allelic losses of the p53 gene were mapped to early preinvasive phases of urothelial neoplasia. The data provide detailed analysis of chromosome 17 allelic losses that occur in the development and progression of urothelial neoplasia and represent the first step for genome-wide modeling of multistep human urothelial carcinogenesis.
Chaturvedi
V
V
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA.
Li
L
L
Hodges
S
S
Johnston
D
D
Ro
J Y
JY
Logothetis
C
C
von Eschenbach
A C
AC
Batsakis
J G
JG
Czerniak
B
B
D000483:Alleles; D002295:Carcinoma, Transitional Cell / Q000235:genetics* / Q000473:pathology; D002874:Chromosome Mapping; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics* / Q000648:ultrastructure; D003043:Cocarcinogenesis; D004273:DNA, Neoplasm / Q000235:genetics; D018450:Disease Progression; D005260:Female; D017353:Gene Deletion; D016158:Genes, p53; D005819:Genetic Markers; D006801:Humans; D008126:Lod Score; D008297:Male; D009092:Mucous Membrane / Q000737:chemistry / Q000473:pathology; D009361:Neoplasm Invasiveness; D011230:Precancerous Conditions / Q000235:genetics / Q000473:pathology; D001743:Urinary Bladder / Q000737:chemistry / Q000473:pathology*; D001745:Urinary Bladder Diseases / Q000235:genetics / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000235:genetics* / Q000473:pathology
D004273:DNA, Neoplasm; D005819:Genetic Markers